This compound is a fluorinated heterocyclic compound used as an intermediate in pharmaceutical manufacturing. Its structure features multiple aromatic rings and an ester functional group, contributing to its role in the synthesis of active pharmaceutical ingredients.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1361232-72-5
Sodium (R)-3-hydroxybutanoate
Pharmaceutical intermediate for drug synthesis
2,4-Dimethylbenzenethiol
Pharmaceutical intermediate
2-Acetyl-6-nitrobenzoic acid
Pharmaceutical intermediate
Ethyl 2-{[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]amino}-3-nitrobenzoate
pharmaceutical intermediate
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
Pharmaceutical intermediate for vericiguat synthesis
5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile
pharmaceutical intermediate
1-[(2-FLUOROPHENYL)METHYL]PYRAZOLO[3,4-B]PYRIDINE-3-CARBONITRILE
research compound
1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridine-3-carboximidamide hydrochloride
research compound
ethyl 5-fluoro-1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridine-3-carboxylate
RTHPGICSOWFJBR-UHFFFAOYSA-N
CCOC(=O)C1=NN(C2=C1C=C(C=N2)F)CC3=CC=CC=C3F
—